Showing results (1651-1660 of 2,516) with videos related to

Sort By:
Pageof 252
Pharmacogenomics and Personalized Medicine|May 8, 2018
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementationRabea Asleh, Alexandros Briasoulis, Elliot M Berinstein, et al.
The Indian Journal of Tuberculosis|September 25, 2017
Predictors of adverse outcome in patients of tuberculous meningitis in a multi-centric study from IndiaRenu Gupta, Suman Kushwaha, Rajeev Thakur, et al.
European Journal of Medicinal Chemistry|November 18, 2017
Synthesis and bio-evaluation of indole-chalcone based benzopyrans as promising antiligase and antiproliferative agentsSampa Gupta, Pooja Maurya, Akanksha Upadhyay, et al.
Micromachines|March 29, 2023
Innovative Fabrication of Hollow Microneedle Arrays Enabling Blood Sampling with a Self-Powered Microfluidic PatchLorenz Van Hileghem, Shashwat Kushwaha, Agnese Piovesan, et al.
Mayo Clinic Proceedings|April 3, 2009
No major neurologic complications with sirolimus use in heart transplant recipientsDiederik van de Beek, Walter K Kremers, Sudhir S Kushwaha, et al.
Indian Pediatrics|March 1, 1994
Growth patterns in breastfed babies during first six months of lifeS Mathur, G P Mathur, U Gupta, et al.
Cureus|March 19, 2024
Functional Outcomes and Gait Analysis of Total Hip Arthroplasty Through Lateral Hardinge Approach and Gluteus Medius-Sparing Approach: A Prospective StudyNarendra S Kushwaha, Ashish Kumar, Rohit Shukla, et al.
FEBS Letters|June 11, 2024
dAsap regulates cellular protrusions via an Arf6-dependent actin regulatory pathway in S2R+ cellsShikha Kushwaha, Bhagaban Mallik, Anjali Bisht, et al.
International Journal of Biological Macromolecules|June 2, 2024
The intrinsically disordered transactivation region of HOXA9 regulates its function by auto-inhibition of its DNA-binding activityNikita V Saibo, Snigdha Maiti, Soumendu Boral, et al.
Chemical Biology & Drug Design|September 13, 2014
Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetesRam N Kushwaha, Rohit Srivastava, Akansha Mishra, et al.
Pageof 252